|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
2006-12-21
|
|
pubmed:abstractText |
The in vitro activities of the lipopeptides palmitoyl (Pal)-Lys-Lys-NH(2) and Pal-Lys-Lys against gram-positive cocci were investigated. Enterococci and streptococci demonstrated higher susceptibilities than staphylococci and Rhodococcus equi. A positive interaction was shown when the lipopeptides were combined with beta-lactams and vancomycin. These results suggest that lipopeptides are promising candidates for antimicrobial therapy for infections caused by gram-positive organisms.
|
|
pubmed:commentsCorrections |
http://linkedlifedata.com/resource/pubmed/commentcorrection/17060532-10227288,
http://linkedlifedata.com/resource/pubmed/commentcorrection/17060532-10348745,
http://linkedlifedata.com/resource/pubmed/commentcorrection/17060532-10590300,
http://linkedlifedata.com/resource/pubmed/commentcorrection/17060532-11841217,
http://linkedlifedata.com/resource/pubmed/commentcorrection/17060532-11871492,
http://linkedlifedata.com/resource/pubmed/commentcorrection/17060532-14529646,
http://linkedlifedata.com/resource/pubmed/commentcorrection/17060532-14674771,
http://linkedlifedata.com/resource/pubmed/commentcorrection/17060532-14709550,
http://linkedlifedata.com/resource/pubmed/commentcorrection/17060532-15907192,
http://linkedlifedata.com/resource/pubmed/commentcorrection/17060532-16008362,
http://linkedlifedata.com/resource/pubmed/commentcorrection/17060532-2191922,
http://linkedlifedata.com/resource/pubmed/commentcorrection/17060532-3614352,
http://linkedlifedata.com/resource/pubmed/commentcorrection/17060532-7019715,
http://linkedlifedata.com/resource/pubmed/commentcorrection/17060532-9597250
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jan
|
|
pubmed:issn |
0066-4804
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
51
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
354-8
|
|
pubmed:dateRevised |
2009-11-18
|
|
pubmed:meshHeading |
pubmed-meshheading:17060532-Anti-Bacterial Agents,
pubmed-meshheading:17060532-Drug Resistance, Multiple, Bacterial,
pubmed-meshheading:17060532-Drug Synergism,
pubmed-meshheading:17060532-Gram-Positive Cocci,
pubmed-meshheading:17060532-Hemolysis,
pubmed-meshheading:17060532-Humans,
pubmed-meshheading:17060532-Lipoproteins,
pubmed-meshheading:17060532-Microbial Sensitivity Tests,
pubmed-meshheading:17060532-Molecular Structure,
pubmed-meshheading:17060532-Peptides
|
|
pubmed:year |
2007
|
|
pubmed:articleTitle |
In vitro activities of the lipopeptides palmitoyl (Pal)-Lys-Lys-NH(2) and Pal-Lys-Lys alone and in combination with antimicrobial agents against multiresistant gram-positive cocci.
|
|
pubmed:affiliation |
Faculty of Pharmacy, Medical University of Gdansk, Gdansk, Poland.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
